Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 12/20 | 0.61 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | F11 | P03951 | 2/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | P4HB | P07237 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4470995 | 0.94 | LIPG (0.71) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL228212 | 0.90 | LPL (0.71) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL18077384 | 0.90 | LIPG (0.61) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL19483212 | 0.88 | LPL (0.50) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL12890199 | 0.88 | LPL (0.51) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL14135626 | 0.88 | P4HB (0.54) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL623833 | 0.88 | CA1 (0.54) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL1505745 | 0.88 | LPL (0.51) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL19055898 | 0.88 | CA1 (0.54) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL18016692 | 0.88 | LPL (0.51) | LPLLIPGCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561818-A | Diaryl substituted 2, 3-indoline compound or medicinal salt thereof, preparation method and application thereof | 河南大学 | 2024-08-30 | — | — | CN | claimed |
| CN-116515091-A | Tetraphenylmethane/dibenzothiophene sulfone covalent organic polymer and preparation method thereof | 台州学院 | 2023-08-01 | — | — | CN | claimed |
| CN-109824520-B | Preparation method of cis-4-methylcyclohexylamine | 苏州海犇药业有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-109824520-A | A kind of preparation method of cis- -4- methyl ring amine | 泰州精英化成医药科技有限公司 | 2019-05-31 | — | — | CN | claimed |
| US-20260050210-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-02-19 | — | — | US | disclosed |
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| EP-4601449-A2 | COMPOUNDS USABLE AS ACTIVE COMPOUNDS IN AN ORGANIC ELECTRONIC DEVICE | Merck Patent GmbH (DE) | 2025-08-13 | — | — | EP | disclosed |
| EP-4190880-B1 | COMPOUNDS USABLE AS ACTIVE COMPOUNDS IN AN ORGANIC ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025128898-A1 | IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE DERIVATIVES AS ENHANCERS OF INNATE IMMUNE RESPONSE FOR THE TREATMENT OF VIRAL INFECTIONS | ASSEMBLY BIOSCIENCES, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-115850002-B | Method for hydrodehalogenating halogenated alkane | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | disclosed |
| US-20250120315-A1 | COMPOUNDS THAT CAN BE USED IN AN ORGANIC ELECTRONIC DEVICE AS ACTIVE COMPOUNDS | MERCK PATENT GMBH (DE) | 2025-04-10 | — | — | US | disclosed |
| US-20250066351-A1 | PYRAZOLO[1,5-A]PYRIDIN-2,3-YL AMIDES AS KV7 CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD (US) | 2025-02-27 | — | — | US | disclosed |
| US-6500951-B1 | RING CLOSING A CARBOXYLIC ACID DERIVATIVE IN PRESENCE OF A NITROGEN CONTAINING AROMATIC COMPOUND AND A BORON COMPOUND; HIGH YIELD AND PURITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-12-31 | — | — | US | disclosed |
| US-6486189-B2 | TREATMENT OR PROPHYLAXIS OF AN ILLNESS CAUSED BY AN ISCHEMIC CONDITION, OR FOR THE TREATMENT OF IMPAIRED RESPIRATORY DRIVE | HOECHST AKTIENGESELLSCHAFT (DE) | 2002-11-26 | — | — | US | disclosed |
| EP-1127060-A4 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2002-08-21 | — | — | EP | disclosed |
| US-20020045761-A1 | Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them | KLEEMANN HEINZ-WERNER (DE) | 2002-04-18 | — | — | US | disclosed |
| US-6335451-B1 | ANTIARRYTHMIA AGENTS, ANTIPROLIFERATIVE AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 2002-01-01 | — | — | US | disclosed |
| EP-1127060-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000027853-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-18 | — | — | WO | disclosed |
| EP-0855392-A2 | Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260050210-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SAME | MAL2, MCM6, MCM3 | LPL 2899/4885LIPG 2909/4885CA1 1842/4885 |
| US-20250066351-A1 | PYRAZOLO[1,5-A]PYRIDIN-2,3-YL AMIDES AS KV7 CHANNEL ACTIVATORS | KCNA7, KCNK17, KCNA1 | LPL 3810/4885LIPG 3741/4885CA1 4753/4885 |
| US-20020045761-A1 | Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them | BAX, BCL2, TNNI3 | LPL 4065/4885LIPG 3803/4885CA1 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.